Animal Diagnostics

Animal Diagnostics Market Outlook

The global animal diagnostics market is projected to reach USD 5.2 billion by 2035, growing at a CAGR of approximately 8.2% during the forecast period. This growth is driven by several factors including the increasing prevalence of zoonotic diseases, rising pet ownership, and the growing demand for rapid and accurate diagnostic testing across veterinary practices. Additionally, advancements in diagnostic technologies and increasing awareness regarding animal health are contributing to market expansion. Moreover, the trend of humanization of pets has led to a heightened focus on health and wellness, propelling the need for effective diagnostic solutions. Veterinary professionals are also becoming more proactive in their approach to animal healthcare, further stimulating the market for diagnostic products and services.

Growth Factor of the Market

The animal diagnostics market is witnessing significant growth owing to a multitude of factors that are reshaping the sector. One of the primary drivers is the rising incidence of infectious diseases in animals, demanding more sophisticated diagnostic tests to ensure timely treatment and control. Additionally, the growing trend towards preventive healthcare in veterinary practices has encouraged pet owners to seek regular check-ups and screenings, resulting in increased demand for diagnostic products. Regulatory changes and government initiatives promoting animal health are also playing a critical role in market expansion. Furthermore, the development of novel diagnostic techniques, such as molecular diagnostics and point-of-care testing, is enhancing the accuracy and efficiency of diagnosis, thus driving market growth. The integration of advanced technologies such as AI and machine learning in diagnostic processes is yet another factor that significantly boosts the market's growth potential. With an increasing focus on animal welfare and the economic implications of livestock diseases on food security, the market is positioned for substantial growth in the coming years.

Key Highlights of the Market

• The global animal diagnostics market is expected to grow at a CAGR of 8.2% from 2025 to 2035.
• Increasing adoption of pets and livestock management practices are accelerating market demand.
• Technological advancements in diagnostic procedures are transforming the veterinary landscape.
• Rising awareness about zoonotic diseases and preventive healthcare is propelling market growth.
• The market is increasingly influenced by regulatory frameworks aimed at ensuring animal health and welfare.

By Product Type

Instruments:

Instruments form a critical component of the animal diagnostics market, encompassing a range of diagnostic tools such as analyzers, imaging equipment, and other electronic devices that assist in the evaluation of animal health. The increasing demand for advanced diagnostic capabilities is driving innovation in this segment, with manufacturers focusing on developing user-friendly and efficient instruments that improve the speed and accuracy of testing. The surge in clinical veterinary practices seeking to adopt digital solutions has further cemented the importance of instruments in this market. As the sophistication of veterinary diagnostics continues to evolve, instruments such as ultrasound machines and hematology analysers are becoming indispensable in veterinary setups, enabling rapid diagnosis and effective treatment planning. The development of portable and point-of-care instruments is also gaining traction, allowing for diagnostic testing in diverse environments such as farms and remote locations, thus broadening access to quality veterinary care.

Consumables:

Consumables are the backbone of the animal diagnostics market, representing reagents, test kits, and other materials utilized in diagnostic procedures. This segment is characterized by a steady demand, driven by the regular need for consumables in veterinary practices. The growth in this segment is largely attributed to an increase in diagnostic testing driven by an emphasis on preventive healthcare and accurate disease management. As more veterinary hospitals and clinics adopt advanced diagnostic technologies, the requirement for high-quality consumables continues to rise. Additionally, innovations in consumable products, such as ready-to-use test kits and advanced reagents, are enhancing testing efficiency and accuracy, thereby attracting more veterinary professionals to utilize these solutions. The expansion of veterinary practices alongside an uptick in pet ownership is further fueling this segment, as consistent testing becomes integral in maintaining animal health and welfare.

By Animal Type

Companion Animals:

Companion animals, particularly dogs and cats, dominate the animal diagnostics market, accounting for a substantial portion of the overall demand. The growing trend of pet humanization is driving pet owners to prioritize their pets' health, leading to an increased focus on diagnostic testing. Health concerns regarding age-related diseases, infectious diseases, and lifestyle-related conditions in companion animals are fueling this demand. Additionally, advancements in diagnostics tailored for these animals, including non-invasive imaging techniques and genetic testing, are attracting more pet owners to seek veterinary assistance. The emergence of specialized veterinary clinics offering comprehensive diagnostic services for companion animals further supports this segment. As the bond between humans and pets strengthens, the need for regular health check-ups and timely diagnostics becomes paramount, reinforcing the growth trajectory of this segment in the animal diagnostics market.

Livestock:

The livestock segment represents a significant portion of the animal diagnostics market, driven by the need for disease management and health monitoring in agricultural settings. With the increasing global population and the corresponding demand for animal protein, farmers are investing in advanced diagnostic technologies to ensure the health and productivity of their livestock. The prevalence of zoonotic diseases and the economic impact of livestock diseases on food security are compelling factors that emphasize the importance of robust diagnostic solutions in this sector. Additionally, government initiatives aimed at controlling and preventing animal diseases have further propelled the adoption of diagnostic testing in livestock management practices. Diagnostic tools such as ELISA tests and PCR assays are extensively utilized for monitoring herd health and ensuring compliance with food safety standards. As livestock owners increasingly recognize the economic benefits of proactive disease management, the demand for high-quality diagnostic solutions in this segment is expected to experience significant growth.

By Application

Clinical Testing:

Clinical testing is a predominant application within the animal diagnostics market, encompassing a variety of tests aimed at diagnosing health conditions in animals. This application is critical in ensuring timely and accurate detection of diseases, which is essential for effective treatment. The rise in chronic and infectious diseases among companion and livestock animals is amplifying the demand for clinical testing services. Innovations in technology, such as automated analyzers and point-of-care testing, are enhancing the efficiency of clinical testing processes, thus improving turnaround times for results. Additionally, there has been a growing trend among veterinary practices to adopt comprehensive testing protocols that include routine screenings as part of preventive healthcare, thereby further driving the need for clinical testing services. The continuous advancements in diagnostic technologies are expected to sustain the growth of this application segment, as veterinary professionals seek reliable solutions for effective animal health management.

Veterinary Imaging:

Veterinary imaging plays a vital role in the animal diagnostics market, providing essential tools for visualizing internal structures and diagnosing medical conditions in animals. Techniques such as X-rays, ultrasound, MRI, and CT scans are increasingly being utilized by veterinary practitioners to obtain detailed insights into an animal's health. The rise in demand for imaging solutions can be attributed to the increasing prevalence of chronic illnesses among companion animals and the need for accurate diagnostics in livestock management. Moreover, advancements in imaging technologies have significantly improved accessibility and affordability, allowing more practices to integrate these diagnostic tools into their services. The growing awareness of the benefits of veterinary imaging, coupled with the push towards specialized veterinary services, is expected to further boost this segment. As veterinarians continue to enhance their diagnostic capabilities, the veterinary imaging application is likely to remain a cornerstone of the animal diagnostics market.

Immunodiagnostics:

Immunodiagnostics is a pivotal application in the animal diagnostics market, utilizing immunological methods to detect diseases and assess immune responses in animals. This segment has gained traction due to the increasing demand for accurate and rapid diagnostic solutions. Immunodiagnostic tests are widely used in both companion and livestock animals for the detection of diseases such as parvovirus in dogs and mastitis in cattle. The advancements in technology, including the development of ELISA kits and rapid tests, have made these diagnostic methods more accessible and user-friendly for veterinary practitioners. Furthermore, the growing focus on preventive healthcare and vaccination programs is driving the adoption of immunodiagnostic tests, as they play a crucial role in monitoring immune status and disease outbreaks. As the importance of immunodiagnostics in veterinary medicine continues to rise, this application is set to contribute significantly to the overall growth of the animal diagnostics market.

Molecular Diagnostics:

Molecular diagnostics has emerged as a transformative application within the animal diagnostics market, leveraging advanced techniques such as PCR and next-generation sequencing to detect genetic material associated with infectious diseases. This application offers unparalleled accuracy and specificity, making it an invaluable tool for veterinarians in diagnosing complex diseases. The increasing prevalence of zoonotic diseases and the growing need for rapid diagnostics are fueling the demand for molecular diagnostics in veterinary medicine. Moreover, the ability to perform genetic tests for breeding and disease susceptibility is gaining popularity among livestock owners, further driving this segment. As technology continues to advance, molecular diagnostics is expected to play an increasingly prominent role in disease management and prevention strategies, positioning it as a key growth area within the animal diagnostics market.

Others:

This category encompasses various niche applications within the animal diagnostics market that do not fall under the major classifications. These may include specialized tests and emerging diagnostic technologies that cater to specific conditions or types of animals. The increasing focus on personalized veterinary medicine is leading to the development of unique diagnostic solutions tailored to individual animal needs. Furthermore, the rise in research and development activities aimed at discovering new diagnostic methods is contributing to the growth of this segment. As veterinary practices evolve to meet the diverse needs of animal health, the "Others" segment is poised for growth, driven by innovations that enhance diagnostic capabilities and improve outcomes in animal healthcare.

By End User

Veterinary Hospitals:

Veterinary hospitals are a crucial end user in the animal diagnostics market, providing comprehensive medical care and diagnostic services for companion and livestock animals. As the primary facilities for veterinary care, these hospitals are increasingly adopting advanced diagnostic technologies to improve patient outcomes and streamline practices. The growing trend of pet humanization has compelled veterinary hospitals to offer a wider array of diagnostic services, including imaging, laboratory tests, and specialized diagnostics for chronic conditions. Furthermore, the emphasis on preventive healthcare is encouraging pet owners to seek regular check-ups and screenings, further boosting the demand for diagnostic services in these facilities. The integration of electronic health records and telemedicine is also enhancing the operational efficiency of veterinary hospitals, enabling them to manage patient care more effectively. As veterinary hospitals continue to evolve and expand their diagnostic capabilities, their contribution to the animal diagnostics market is expected to grow significantly.

Veterinary Clinics:

Veterinary clinics represent another vital end user segment within the animal diagnostics market, primarily catering to routine care and preventive health services for companion animals. These clinics are increasingly integrating diagnostic services into their offerings to enhance patient care and address the demand for rapid testing solutions. The rise in pet ownership and the growing awareness among pet owners about the importance of regular health screenings are driving the adoption of diagnostic tools in veterinary clinics. Moreover, advancements in point-of-care testing and portable diagnostic devices are making it easier for clinics to conduct tests on-site, reducing the need for referrals to larger veterinary hospitals. This shift towards in-clinic diagnostics is empowering veterinarians to provide immediate care and treatment, thus improving outcomes for their patients. As the landscape of veterinary care evolves, veterinary clinics are likely to remain integral to the growth of the animal diagnostics market.

Diagnostic Laboratories:

Diagnostic laboratories play a pivotal role in the animal diagnostics market by providing specialized analytical services and in-depth testing for various animal health issues. These laboratories are equipped with advanced technologies and skilled personnel, enabling them to conduct a wide range of diagnostic tests, from routine screenings to complex analyses. The increasing complexity of animal diseases and the need for accurate diagnostic results drive the demand for laboratory services among veterinary practitioners. Furthermore, as veterinary practices increasingly rely on external laboratories for specialized testing, the collaboration between diagnostic laboratories and veterinary clinics is becoming more pronounced. This partnership allows veterinary professionals to access a broader array of testing options and obtain detailed insights into health conditions, thereby enhancing patient care. The continual investment in laboratory technology and the growth of veterinary diagnostics are expected to position diagnostic laboratories as key players in the animal diagnostics market.

Others:

This category includes various other end users such as research institutions, animal shelters, and regulatory bodies that utilize diagnostic services for various purposes. Research institutions rely on animal diagnostics for studies related to veterinary medicine, zoonotic disease research, and vaccine development, contributing to the growth of this segment. Animal shelters also increasingly seek diagnostic services to ensure the health and well-being of animals before adoption. Additionally, regulatory bodies depend on animal diagnostics to monitor and control disease outbreaks, ensuring food safety and public health. As the importance of animal health continues to rise globally, the "Others" segment is likely to gain prominence within the animal diagnostics market, driven by a diverse array of needs and applications.

By Region

The regional analysis of the animal diagnostics market highlights significant variations in growth and demand across different geographies. North America is anticipated to dominate the market due to the high prevalence of pet ownership and the presence of advanced veterinary healthcare infrastructure. The region is expected to account for approximately 40% of the global market share by 2035, with a robust CAGR of 7.8% during the forecast period. The growing trend of pet humanization and rising awareness about preventive healthcare are key factors driving market growth in this region. In addition, the United States and Canada are witnessing substantial investments in veterinary services and diagnostics, further enhancing the market landscape. The emphasis on research and development in veterinary medicine within North America also plays a crucial role in the advancement of diagnostic technologies.

Europe is another critical region in the animal diagnostics market, projected to hold about 30% of the global market share by 2035. The region is characterized by a well-established veterinary healthcare system and a growing focus on animal welfare. European countries, particularly the UK, Germany, and France, are leading in the adoption of innovative diagnostic solutions, spurred by regulatory frameworks that prioritize animal health. The CAGR for Europe is estimated at 6.5%, influenced by the increasing adoption of advanced diagnostic technologies and the rising demand for veterinary care services. Meanwhile, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by a surge in pet ownership and increased investments in veterinary healthcare infrastructure, making it an emerging market for animal diagnostics.

Opportunities

The animal diagnostics market is poised for considerable growth opportunities in the coming years, particularly in the realm of technological advancements. The integration of digital solutions and artificial intelligence in diagnostic processes is opening new avenues for improved accuracy and efficiency. Companies that invest in innovative technologies such as machine learning algorithms for data analysis and point-of-care testing solutions stand to gain a competitive edge. Moreover, the growing trend of telemedicine in veterinary practices presents an opportunity for diagnostic providers to develop remote diagnostic technologies, allowing for quicker and more accessible services for pet owners. As veterinary practices increasingly embrace a proactive approach to animal health, these technological advancements will be pivotal in driving market growth.

Additionally, the increasing global awareness of zoonotic diseases poses an opportunity for the animal diagnostics market. As healthcare authorities and governments focus on creating policies aimed at disease prevention and control, there will be a growing demand for diagnostic testing services in both companion and livestock animals. The potential for collaboration between veterinary and public health sectors can lead to the development of comprehensive surveillance systems, ensuring early detection and management of diseases. Furthermore, the expansion of veterinary practices in emerging markets and the rising disposable income among pet owners further signify a positive outlook for growth. The animal diagnostics market is thus well-positioned to capitalize on these opportunities in the foreseeable future.

Threats

Despite the promising growth prospects, the animal diagnostics market faces several threats that could hinder its progress. One of the primary challenges is the rising cost of advanced diagnostic technologies, which may limit access for smaller veterinary practices, particularly in developing regions. The high capital investment required for sophisticated diagnostic equipment can deter practices from upgrading or expanding their diagnostic capabilities. Additionally, the increasing competition among diagnostic product manufacturers may lead to price wars, adversely affecting profit margins and potentially compromising the quality of diagnostic services. Furthermore, the market is susceptible to regulatory changes that can impose additional compliance costs on diagnostic providers, creating barriers to entry for new companies.

Moreover, the prevalence of counterfeit and substandard diagnostic products poses a significant threat to the market. As the demand for animal diagnostics increases, so does the likelihood of inferior products flooding the market, which can undermine the trust veterinary professionals have in diagnostic solutions. The need for stringent quality control measures and regulatory oversight is critical to mitigate this risk. Overall, while the animal diagnostics market presents numerous opportunities, stakeholders must navigate these threats to ensure sustainable growth and maintain the integrity of the diagnostic solutions offered.

Competitor Outlook

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Heska Corporation
• Virbac S.A.
• Neogen Corporation
• QIAGEN N.V.
• Boehringer Ingelheim
• Agilent Technologies, Inc.
• Roche Diagnostics
• Laboklin GmbH
• Alere Inc.
• Synlogic, Inc.
• Genetic Veterinary Sciences, Inc.
• Randox Laboratories Ltd.

The competitive landscape of the animal diagnostics market is characterized by the presence of several established players and emerging companies striving to capture market share through innovation and quality offerings. Key companies such as Idexx Laboratories and Zoetis dominate the market with their extensive product portfolios ranging from clinical diagnostics to specialty tests. These companies benefit from strong brand recognition, established distribution networks, and significant investments in research and development, enabling them to deliver cutting-edge diagnostic solutions to veterinary practices. Additionally, companies like Thermo Fisher Scientific and Heska Corporation are making strides in technological advancements, offering state-of-the-art diagnostic instruments and reagents that cater to the evolving needs of the veterinary sector.

Furthermore, the market is witnessing a trend towards collaborations and partnerships aimed at enhancing product offerings and expanding market reach. For instance, companies are increasingly engaging in strategic alliances with veterinary clinics and research institutions to foster innovation and improve service delivery. This collaborative approach not only enhances the product range but also facilitates the sharing of knowledge and expertise, ultimately benefiting the end users. As new players enter the market with innovative solutions, the competitive dynamics will continue to evolve, presenting both challenges and opportunities for existing companies to adapt and thrive in the changing landscape.

In addition to established players, several emerging companies are entering the animal diagnostics market, focusing on niche segments and specialized testing solutions. These companies leverage advancements in technology to create unique diagnostic products that address specific health concerns in animals. For example, genetic testing companies are gaining traction by offering tests that assess genetic predispositions to certain diseases in pets and livestock. As the market grows, these smaller players are expected to play a significant role in driving innovation and shaping the future of animal diagnostics. Overall, the competitive landscape is dynamic, with both established companies and emerging players contributing to the ongoing evolution of the animal diagnostics market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alere Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 QIAGEN N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Virbac S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zoetis Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Laboklin GmbH
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Synlogic, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Heska Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Neogen Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Boehringer Ingelheim
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Idexx Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Randox Laboratories Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Agilent Technologies, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Genetic Veterinary Sciences, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Animal Diagnostics Market, By End User
    • 6.1.1 Veterinary Hospitals
    • 6.1.2 Veterinary Clinics
    • 6.1.3 Diagnostic Laboratories
    • 6.1.4 Others
  • 6.2 Animal Diagnostics Market, By Animal Type
    • 6.2.1 Companion Animals
    • 6.2.2 Livestock
  • 6.3 Animal Diagnostics Market, By Application
    • 6.3.1 Clinical Testing
    • 6.3.2 Veterinary Imaging
    • 6.3.3 Immunodiagnostics
    • 6.3.4 Molecular Diagnostics
    • 6.3.5 Others
  • 6.4 Animal Diagnostics Market, By Product Type
    • 6.4.1 Instruments
    • 6.4.2 Consumables

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Animal Diagnostics Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Animal Diagnostics market is categorized based on

By Product Type

• Instruments
• Consumables

By Animal Type

• Companion Animals
• Livestock

By Application

• Clinical Testing
• Veterinary Imaging
• Immunodiagnostics
• Molecular Diagnostics
• Others

By End User

• Veterinary Hospitals
• Veterinary Clinics
• Diagnostic Laboratories
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Heska Corporation
• Virbac S.A.
• Neogen Corporation
• QIAGEN N.V.
• Boehringer Ingelheim
• Agilent Technologies, Inc.
• Roche Diagnostics
• Laboklin GmbH
• Alere Inc.
• Synlogic, Inc.
• Genetic Veterinary Sciences, Inc.
• Randox Laboratories Ltd.